Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jan 19:2020:6532827.
doi: 10.1155/2020/6532827. eCollection 2020.

Multitarget Therapeutics for Neurodegenerative Diseases

Moustafa T Gabr  1 , Samir Yahiaoui  2
Affiliations
Editorial

Multitarget Therapeutics for Neurodegenerative Diseases

Moustafa T Gabr et al. Biomed Res Int. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The guest editors declare that there are no conflicts of interest regarding the publication of this special issue.

References

    1. Lin M. T., Beal M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787–795. doi: 10.1038/nature05292. - DOI - PubMed
    1. Ibrahim M. M., Gabr M. T. Multitarget therapeutic strategies for Alzheimer’s disease. Neural Regeneration Research. 2019;14(3):437–440. doi: 10.4103/1673-5374.245463. - DOI - PMC - PubMed
    1. Hiremathad A., Piemonese L. Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer’s disease therapy. Neural Regeneration Research. 2017;12(8):1256–1261. doi: 10.4103/1673-5374.213541. - DOI - PMC - PubMed
    1. Kupershmidt L., Amit T., Bar-Am O., Youdim M. B. H., Weinreb O. Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice. Mechanisms of Ageing and Development. 2012;133(5):267–274. doi: 10.1016/j.mad.2012.03.001. - DOI - PubMed

Publication types

MeSH terms

Substances